Sg3 Management, LLC Bausch Health Companies Inc. Transaction History

Sg3 Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$7.06 - $23.63 $6.28 Million - $21 Million	-889,500 Reduced 53.58%	770,500 $6.44 Million
Q1 2022 May 16, 2022	BUY	$21.6 - $27.79 $24.2 Million - $31.1 Million	1,119,000 Added 206.84%	1,660,000 $37.9 Million
Q4 2021 Feb 15, 2022	BUY	$23.0 - $29.01 $6 Million - $7.57 Million	261,000 Added 93.21%	541,000 $14.9 Million
Q3 2021 Nov 15, 2021	BUY	$25.04 - $30.06 $6.54 Million - $7.85 Million	261,000 Added 1373.68%	280,000 $7.8 Million
Q2 2021 Aug 16, 2021	BUY	$27.43 - $32.7 $246,870 - $294,300	9,000 Added 90.0%	19,000 $557,000
Q1 2021 May 17, 2021	BUY	$21.37 - $34.38 $213,700 - $343,800	10,000 New	10,000 $317,000

254

253M

5.53M

16.5M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.67B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of Sg3 Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sg3 Management, LLC with notifications on news.